World Investment Advisors’s Zevra Therapeutics ZVRA Stock Holding History

World Investment Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,000	Closed	-$50.5K	–	269
2022 Q4	$50.5K	Sell	11,000 -5,350	-33%	-$27.2K	0.01%	237
2022 Q3	$102K	Buy	16,350 +3,000	+22%	+$17K	0.02%	240
2022 Q2	$78K	Sell	13,350 -1,000	-7%	-$4.56K	0.02%	257
2022 Q1	$72K	Hold	14,350	–	–	0.01%	268
2021 Q4	$94K	Buy	14,350 +1,000	+7%	+$8.92K	0.02%	264
2021 Q3	$125K	Hold	13,350	–	–	0.03%	246
2021 Q2	$171K	Sell	13,350 -500	-4%	-$5.37K	0.04%	243
2021 Q1	$118K	Buy	+13,850	New	+$121K	0.03%	223

Other funds holding ZVRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MAM

Mystic Asset Management Warwick, Rhode Island $468M AUM 30.94% 1-Year Est. Return

World Investment Advisors's ZVRA Position: Q1 2023 in Review

World Investment Advisors sold out of Zevra Therapeutics (ZVRA) in Q1 2023, closing a stake of 11,000 shares — an estimated $50.5K sold.

World Investment Advisors first reported a position in ZVRA in Q1 2021 and held it in 8 quarters. The position peaked at $171K in Q2 2021. 60 funds tracked by Wall St. Rank hold ZVRA as of Q1 2023.

World Investment Advisors reported no remaining Zevra Therapeutics position as of Q1 2023 after selling out during the quarter.
World Investment Advisors sold 11,000 Zevra Therapeutics shares in Q1 2023, an estimated $50.5K.
World Investment Advisors first reported a position in Zevra Therapeutics in Q1 2021 and held it in 8 quarters.
World Investment Advisors's Zevra Therapeutics position peaked at $171K in Q2 2021.
60 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2023.

Based on World Investment Advisors's 13F filing for Q1 2023, filed 15 May 2023.